Ethereum, Solana, Binance Coin: Altcoin Rally on the Horizon?by John Darbie 21.06.2024Ethereum, Solana, and Binance Coin show signs of potential altcoin rally amid key level holds and market recovery. Experts highlight ...
Fintech Solutions: Greening MSMEs Through Green Financeby Mark Eisenberg 21.06.2024Discover how fintech innovations enable MSMEs to secure green finance, integrate eco-friendly practices, and achieve sustainable growth.
Aureus Greenway Holdings Sets $4-$6 IPO Price for 3.75M Sharesby Mark Eisenberg 21.06.2024Aureus Greenway Holdings files for 3.75M share IPO at $4-$6/sh to raise funds for expansion, highlighting risks and investment considerations.
$30 Million Renovation Approved for BGSU Tech Buildingby Lilu Anderson 21.06.2024BGSU announces a $30M renovation of its technology building, modernizing facilities with updated equipment, sustainable design, and collaborative spaces.
New Research Questions Cryptocurrencies’ Safe Haven Statusby John Darbie 21.06.2024New study reveals cryptocurrencies' 'safe haven' status isn't foolproof, highlighting their vulnerability to economic and geopolitical risks.
How OTT Apps Revolutionize Hotel Guest Technologyby Lilu Anderson 21.06.2024Discover how OTT apps and smart TVs are revolutionizing in-room entertainment in hotels, enhancing guest satisfaction and streamlining costs.
Anthropic’s Claude 3.5 Sonnet Now in Amazon Bedrockby Lilu Anderson 21.06.2024Anthropic’s Claude 3.5 Sonnet, now in Amazon Bedrock, excels in customer support, content creation, and analytics, while being 80% cheaper ...
Konami’s Avalanche NFT Push: Gaming Revolution or Cash Grab?by John Darbie 21.06.2024Konami’s Resella platform, built on Avalanche, aims to simplify NFT integration in gaming, sparking debate over its impact on gameplay ...
Ethereum At A Crossroads: Big Move After Consolidation?by John Darbie 20.06.2024Ethereum at a crucial point as it enters a consolidation phase; traders eye potential volatility. Will ETH break out or ...
ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cutby Mark Eisenberg 20.06.2024Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...